GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yonghe Medical Group Co Ltd (HKSE:02279) » Definitions » COGS-to-Revenue

Yonghe Medical Group Co (HKSE:02279) COGS-to-Revenue : 0.39 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Yonghe Medical Group Co COGS-to-Revenue?

Yonghe Medical Group Co's Cost of Goods Sold for the six months ended in Dec. 2024 was HK$373 Mil. Its Revenue for the six months ended in Dec. 2024 was HK$965 Mil.

Yonghe Medical Group Co's COGS to Revenue for the six months ended in Dec. 2024 was 0.39.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Yonghe Medical Group Co's Gross Margin % for the six months ended in Dec. 2024 was 61.35%.


Yonghe Medical Group Co COGS-to-Revenue Historical Data

The historical data trend for Yonghe Medical Group Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yonghe Medical Group Co COGS-to-Revenue Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial 0.25 0.27 0.38 0.44 0.40

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.44 0.44 0.41 0.39

Yonghe Medical Group Co COGS-to-Revenue Calculation

Yonghe Medical Group Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=769.029 / 1926.612
=0.40

Yonghe Medical Group Co's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=373.173 / 965.491
=0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yonghe Medical Group Co  (HKSE:02279) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Yonghe Medical Group Co's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 373.173 / 965.491
=61.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Yonghe Medical Group Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Yonghe Medical Group Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Yonghe Medical Group Co Business Description

Traded in Other Exchanges
Address
20 Ganluyuan Nanli, China Nuclear E&C Building, 3A/F, Chaoyang District, Beijing, CHN, 100020
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. It is principally engaged in the provision of hair transplant services, which are subject to similar types of services, similar classes of customers, similar regulatory environment, and similar business risk. The company generated the majority of its revenue from hair transplant services. It offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
Executives
Zhang Yu 2307 Founder of a discretionary trust who can infl
Cyh Cosmetic Medical Investment Limited
Pan Mao Shang Hai Tou Zi Zhong Xin You Xian He Huo
Shang Hai Pan Nuo Qi Ye Guan Li Fu Wu You Xian Gong Si
Zhong Xin Chan Ye Tou Zi Ji Jin Guan Li You Xian Gong Si
Zy Ventures Ltd
Zy Investment Capital Ltd
Yonghe Hair Service Holdings Limited
Cyh Cosmetic Medical Holdings Limited
Cpechina Fund Iia, L.p.
Cpechina Fund Ii, L.p.
Citron Pe Holdings Limited
Citron Pe Funds Ii Limited
Citron Pe Associates Ii, L.p.
Citic Securities Company Limited

Yonghe Medical Group Co Headlines

No Headlines